Industry News
Immuron to raise $9.6m in rights issue
Immuron (ASX:IMC) has commenced a $9.6m capital raising, for purposes including raising funds for upcoming phase IIb trial of IMM-124E in NASH. [ + ]
ANSTO celebrates the International Year of Crystallography
The study of crystallography - the only technique for examining the arrangement and structure of matter or materials at the atomic or molecular level - is around 100 years old. In light of this, the United Nations Educational, Scientific and Cultural Organisation (UNESCO) has declared 2014 the International Year of Crystallography (IYCr2014). [ + ]
Review resumes on employee share schemes for start-ups
The federal government has resumed a review on Employee Share Schemes that had paused pre-election when the government entered caretaker mode. Submissions that were lodged previously with the government will be considered as part of this consultation process and new submissions will be accepted now. [ + ]
Hookworm genome sequenced
The genome of the hookworm, the most common soil-transmitted parasitic worm, has been sequenced. [ + ]
Regeneus lines up manufacturer for US CryoShot trial
Global stem cell manufacturer Lonza has agreed to produce the stocks of Regeneus' (ASX:RGS) cell therapy CryoShot Canine for an upcoming US marketing study. [ + ]
University of Melbourne and Sanofi Pasteur to develop human vaccines
Sanofi Pasteur has signed a vaccine development agreement with the University of Melbourne. The alliance was facilitated by UoM Commercial, the university's commercial engagement services company. [ + ]
Old trees continue to grow and store more carbon
An international study has found that trees do not slow in their growth rate as they get older and larger. In some cases, large trees appear to be adding the carbon mass equivalent of an entire mid-sized tree each year and are thus better at absorbing carbon from the atmosphere than previously thought. [ + ]
Federal funding to fight cancer and other diseases
The federal government has awarded $8 million to three La Trobe University scientists for research into next-generation immunological and plant-based therapies for cancer and other diseases. [ + ]
Qiagen and Exosome Diagnostics to develop diagnostics for genetic biomarkers in cancers
Qiagen and Exosome Diagnostics have expanded their strategic partnership to develop non-invasive, in-vitro molecular diagnostics for detecting and monitoring actionable genetic mutations in lung-cancer patients. [ + ]
Bioluminescence alliance receives ARC Linkage Grant
A team of world leaders in the field of biomolecular interaction, relating to basic biomedical research and the discovery of new pharmaceuticals, has been the recipient of an Australian Research Council (ARC) Linkage Grant. [ + ]
Australia expands its role in the hunt for gravitational waves
Physicists from around Australia today met at the Australian International Gravitational Research Centre (AIGCRC), in Gingin, WA, to launch a nationwide project that expands our participation in the hunt for elusive gravitational waves. [ + ]
2014 - International Year of Crystallography
The United Nations has proclaimed 2014 as the International Year of Crystallography. [ + ]
Imugene adds to scientific board
Imugene has appointed to its scientific advisory board two Austrian scientists who were instrumental in the development of the company's cancer vaccine candidate HER-Vaxx. [ + ]
Phosphagenics in for Indian royalties from TPM gels
Phosphagenics' (ASX:POH) Indian partner Themis and Novartis are both launching into the Indian market diclofenac gel products which use Phosphagenics' TPM drug-delivery technology. [ + ]
Economic industry reviews for Vic and SA to inform manufacturing transition
In a call for submissions, federal Industry Minister Ian Macfarlane has announced reviews for Victoria and South Australia to guide Australia's transition to "a new era of manufacturing and competitiveness" in preparation for the departure of Ford and Holden's manufacturing. [ + ]